Tamara Thomas

Urban Health Today

Metabolic syndrome (MetS) affects patients with psoriatic arthritis (PsA) and rheumatoid arthritis (RA) differently, with the cardiovascular risk being stronger in PsA compared with RA, according to a study published in the Journal of Clinical Medicine.Previous studies have revealed a higher prevalence of all CV risk factors in PsA patients, whereas only diabetes and obesity were found to be increased in RA. However, whether MetS clinical presentation and their components were comparable across both conditions remains unclear.For this study, Dr. Fabiola Atzeni and colleagues compared MetS prevalence and impact on the CV risk in PsA to RA. Their study included 170 patients referred to a Rheumatology clinic. Of the participants, 78 had PsA, and 92 had RA. The researchers looked at their mean age at diagnosis, disease duration, presence of MetS, and other risk factors.The researchers observed that although most variables were comparable, patients in the PsA cohort were younger and reported a shorter disease duration. Twice as many PsA patients also reported the presence of MetS than PsA (51.3% vs 27.2%), and almost three times as many patients in the PsA cohort had dyslipidemia than PsA (71.8% vs 28.3%). The history of cardiovascular events was comparable between both groups.The study revealed hypertension and metabolic syndrome are both risk factors for cardiovascular events (CV events) in people with PsA, but dyslipidemia is a risk factor significantly associated with CV events in people with RA.Generally, the association between traditional risk factors of MetS (older age, male gender, smoking, hypertension, dyslipidemia, and diabetes) with CV events is stronger in PsA than in RA. This is supported by the fact that the coefficient of determination (R^2) is greater in the PsA cohort than in the RA cohort (0.70 vs 0.30).&ldquo;These findings are relevant for clinical practice as a disease-specific management of cardiovascular risk may be required in distinct chronic inflammatory diseases of the joints,&rdquo; the researchers concluded. &ldquo;However, clinical validation in larger studies is needed. Further efforts are required to develop disease-specific strategies for managing cardiovascular risk in PsA and RA.&rdquo;&nbsp;Source: <a href="https://www.hcplive.com/view/metabolic-syndrome-presents-differently-in-rheumatoid-psoriatic-arthritis">HCPLive</a>Journal Source: <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420311/">Journal of Clinical Medicine</a>

Payton White, BS

How Sleep Quality Influences Risk of Alzheimer’s Disease

Alzheimer's & Dementia

Lou Portero

Hidden Dangers: The Blood Sugar Crisis in Modern Breast Cancer Treatment

Diabetes in Women

New ACG Guidelines Address Critical Gastric Cancer Disparities in Non-White Americans

Gastroenterology

Latest News

Metabolic Syndrome Linked to Stronger Cardiovascular Risk in Psoriatic Arthritis Patients

Rheumatology

Researchers compared MetS prevalence and impact on the CV risk in PsA to RA.

About Us

Editorial Policy

Contributors & Partners

Contact Us

eNewsletters

Work With Us

Advertising

Career Center

GU Oncology Now

Blood Cancers Today

Cancer Nursing Today

DocWire News

MashupMD

Food Allergy Roundtable Discussions

Allergy

Blood Cancers

— Multiple Myeloma

Breast Cancer

Colorectal Cancer

Pancreatic Cancer

Prostate Cancer

Cancer

Diabetes

Heart Failure

Heart Disease Prevention

Heart Health

— Alzheimer’s Disease

Neurology

Public Health

Autoimmune Disease

Infectious Diseases

Obesity

Pediatrics

Sickle Cell Disease

Digital Health

Dermatology

Pulmonology

Video Insights

Workforce News

More

Gynecologic Cancer

Heart Disease in Women

Menopause

Reproductive Health

Women’s Neurology

Well Woman Today

Roundtables

Podcasts

Conferences

Viewpoints

Subscribe